Nilesh Pandey, Harpreet Kaur, Mehul R Chorawala, Sumit Kumar Anand, Lakshmi Chandaluri, Megan Butler, Richa Aishwarya, Shiva Jashwanth Gaddam, Xinggui Shen, Mabruka Alfaidi, Jian Wang, Xiaolu Xhang, Kavitha Beedupalli, Md Shenuarin Bhuiyan, Mohammad Alfrad Nobel Bhuiyan, Prabandh Buchhanolla, Prashant Rai, Rahul Shah, Himanshu Chokhawala, Dedrick Jordan, Tarek Magdy, A Wayne Orr, Karen Y Stokes, Oren Rom, Nirav Dhanesha
Venous thromboembolic events are significant contributors to morbidity and mortality in patients with stroke. Neutrophils are among the first cells in the blood to respond to stroke and are known to promote deep vein thrombosis (DVT). Integrin α9 is a transmembrane glycoprotein, highly expressed on neutrophils and stabilizes neutrophil adhesion to activated endothelium via vascular cell adhesion molecule 1 (VCAM-1). Nevertheless, the causative role of neutrophil integrin α9 in post-stroke DVT remains unknown...
March 18, 2024: Blood Advances